SIGA Technologies is a commercial-stage pharmaceutical company. Co. sells its primary product, TPOXX® (oral TPOXX®), to the U.S. government and international governments (including government affiliated entities). Additionally, Co. sells the intravenous formulation of TPOXX® to the U.S. Government. TPOXX® is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. Co. has been delivering oral TPOXX® to the U.S. Strategic National Stockpile. When considering the SIGA Technologies Inc stock dividend history, we have taken known splits into account, such that the SIGA dividend history is presented on a split-adjusted ("apples to apples") basis. SIGA Technologies Inc dividend history is presented both in graphical/chart form, and as a SIGA dividend history data table along the right-hand column.
|
SIGA Stock Dividend HistoryThe SIGA dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable SIGA historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the SIGA dividend history record. Also see the SIGA stock dividend history data table along the right-hand column below. |
|
SIGA Next Dividend Date » (Projection based upon history) SIGA Dividend Growth Rate » Quotes delayed 20 minutes |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
Projection: SIGA Next Dividend Date Chart: SIGA Chart - 5Yr Dividend Yield |